| Literature DB >> 26603772 |
Yi Li1, Meng Wang2, Yanxia Gao3, Wen Yang4, Qun Xu5, Michael Eddleston6, Li Li3, Xuezhong Yu1.
Abstract
Ingestion of paraquat causes multi-organ failure. Prognosis is best estimated through measurement of blood paraquat concentrations but this facility is not available in most hospitals. We studied the prognostic significance of abnormal pancreatic enzymes for survival. Patients with acute paraquat poisoning were recruited. An extensive series of blood tests including serum amylase were serially checked. Patients were sorted according to their serum amylase activity (normal [<220 U/L], mildly elevated [220 to 660 U/L], elevated [>660 U/L]), and survival compared between groups. 177 patients were enrolled to the study, of whom 67 died and 110 survived. 122 (70.62%), 27 (15.25%) and 25 (14.13%) patients were in the normal, mildly elevated and elevated amylase activity groups, respectively. The case fatality in the elevated group was 100% compared to 17% in the normal group (P < 0.001). We found four independent factors for paraquat death prediction: amylase, PaCO2, leukocyte number, and neutrophil percentage. Models using pancreatic enzyme activity showed good prediction power. We have found that abnormal pancreatic enzymes are useful prognostic marker of death after acute paraquat poisoning. Including serum amylase activity into a prognostic model provides a good prognostication.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26603772 PMCID: PMC4658566 DOI: 10.1038/srep17299
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow chart of study recruitment.
Patient demographics (n = 177).
| Characteristic | value |
|---|---|
| Age (year, median IQR) | 29 (22 to 43) |
| Male (%) | 97 (56.1%) |
| GCS (median, IQR) | 15 (14 to 15) |
| Ingestion volume (mL, median IQR) | 30 (10 to 60) |
| Urine paraquat concentration (ug/mL, median IQR) | 27.3 (5.1 to 72.9) |
| Delay from ingestion to admission (hr, median IQR) | 7 (5 to 10) |
IQR: interquartile range.
Frequency of pancreatic injury.
| Group | Number (%) | Deaths (% of all deaths) | Case fatality (95% CI) |
|---|---|---|---|
| Normal | 125 (70.6) | 21 (31.3) | 0.17 (0.11 to 0.24) |
| Mildly elevated | 27 (15.3) | 21 (31.3) | 0.78 (0.59 to 0.89) |
| Elevated | 25 (14.1) | 25 (37.3) | 1.00 (0.87 to 1.00) |
Figure 2Survival curves for the groups according to the level of amylase.
Blue solid line: elevated group; red dotted line: mildly elevated group; green dotted line: normal group.
Figure 3Daily kinetic change of amylase and lipase according to outcome.
Red dotted line: lipase of the deceased group; purple dotted line: amylase of the deceased group; green solid line: amylase of the survival group; blue dotted line: lipase of the survival group. There were 48 patients in the survival group, and 18 patients in the deceased group.
Figure 4ROC for the factors with significant difference in the multi-logistic Regression.
Comparison of the prediction model with traditional scores.
| Best cutoff (>) | Sensitivity (%) | Specifity (%) | Diagnosis Accuracy (%) | Youden index | AUC | |
|---|---|---|---|---|---|---|
| SOFA | 9 | 77.61 | 87.27 | 83.62 | 0.65 | 0.889 |
| PSS | 3 | 100 | 98.18 | 98.87 | 0.98 | 0.990 |
| APACHE2 | 14 | 97.01 | 93.64 | 94.92 | 0.91 | 0.975 |
| PI1 | 0.46 | 77.61 | 99.08 | 90.1 | 0.767 | 0.903 |
| PI2 | 0.18 | 100 | 96.33 | 99.6 | 0.963 | 0.996 |
PI1: model incorporating pancreatic enzymes including amylase and lipase.
PI2: model incorporating leukocyte, amylase, neutrophil percent (N%), and PaCO2.